SlideShare a Scribd company logo
CHAIR PERSON – DR. KALINGA.B.E
STUDENT – DR. MAMATARANI
MANAGEMENT OF ACUTE ISCHEMIC
STROKE
WHO DEFINITION OF STROKE
A NEUROLOGICAL DEFICIT OF
• Sudden onset
• With focal rather than global dysfunction
• In which, after adequate investigations, symptoms are
presumed to be of non-traumatic vascular origin and
• last for >24 hours
BLOOD SUPPLY OF BRAIN
TYPES OF STROKE
85%
Ischemic
15 %
Hemorrhagic
Principles of acute stroke care
(1) achieve timely recanalization of the occluded artery and
reperfusion of the ischemic tissue,
(2) optimize collateral flow, and
(3) avoid secondary brain injury.
Stroke Risk Factors Non-
modifiable
 AGE
 Gender - male
 Race – Blacks > Asians or Hispanics> Whites
 Family History.
 Coagulation Disorders
 Cardiac Disease
Stroke Risk Factors Modifiable
 Hypertension
 Diabetes mellitus
 Hypercholesterolemia
 Elevated LDL or Low HDL
 Elevated homocystein
 Smoking
• Alcohol Abuse
•OralContraceptive
• Pregnancy
•Obesity
•Sleep apnea
•Carotid stenosis
Stroke chain of survival
 Detection Recognition of stroke signs/symptoms
 Dispatch Call 119 and priority EMS dispatch
 Delivery Prompt transport and prehospital notification to Hospital
 Door Immediate ED triage
 Data ED evaluation, prompt laboratory studies, and
CT Imaging
 Decision Diagnosis and decision about appropriate therapy
 Drug Administration of appropriate drugs or other intervention
EMERGENCY EVALUATION OF ACUTE
ISCHEMIC STROKE
 Assess ABCs, vital signs
 Provide oxygen by nasal cannula wherever necessary
 Obtain IV access; obtain blood samples (CBC, ’lytes,
coagulation studies)
 Obtain 12-lead ECG, check rhythm, place on monitor
 Check blood sugar; treat if indicated
NIHSS
MEDICAL MANAGEMENT
 Supportive treatment
 IV thrombolysis
 Endovascular revascularization
 Anti thrombotic tretment
 Neuroprotection
 Stroke centers and Rehabilitation
SURGICAL MANAGEMENT
 Endovascular intervention
1.angioplasty and stenting
2. Mechanical clot disruption
3. clot extraction
• Carotid end artrectomy
MANAGEMENT OF COMPLICATION
 Cerebral edema
 Hemorrhagic transformation
 seizures
SUPPORTIVE TREATMENT
 Airway, Breathing and Circulation.
 Temperature
 Blood pressure
 Blood glucose
When to lower Blood pressure
 the hypertension is extreme (systolic blood pressure >220
mmHg or diastolic blood pressure >120 mmHg)
 Acute myocardial infarction
 Aortic dissection
 Hypertensive encephalopathy
 Acute renal failure
THROMBOLYSIS FOR AIS
 IV rtPA Dose - 0.9mg/kg to a 90mg maximun dose..
 Before IV rtPA ensure that blood pressure is not More
than 185/110 mmhg
 Door to needle time should be within 60min.
INTRAARTERIAL THROMBOLYSIS
MECHANICAL / ENDOVASCULAR
METHODS
 CRITERIA FOR MECHANICAL
THROMBECTOMY
1.prestroke mRS score of 0-1
2.occlusion of the internal carotid artery or MCA segment
1
3.age >18yr
4.NIHSS score> 6
5.ASPECT score of >6
6. treatment can be initiated (groin puncture) within 6
hours of sypmtom onset
ANTIPLATELETS.
 The oral administration of aspirin in AIS is
recommended within 24 -48 hrs of symptoms
onset.
 For those treated with IV alteplase, aspirin
administration is generally delayed until 24 hours
later
ROLE OF DUALANTIPLATELETS???
ANTICOAGULANTS
NEUROPROTECTION
CLINICAL SCENARIO
 A 70-year-old, right-handed man has been known to have previous
historyofpoorlycontrolledhypertension, diabetes,andcardiacarrhythmia.
Hedevelopedabrupt onsetofleft-sidedweaknessafterdinnerat7 pm
What should you do?
• Hebrought to a medicalcenterERbytheEMSat 8:30
pm
• OninitialERarrival,hisconsciousnesswasawake,
• blood pressure was 210/120 mmHg, pulse rate was
120/min irregularly, respiratory rate was 20/min, body
temperaturewas37°Candbloodsugarwas320mg/dL
 Neurologically,hehadflaccidhemiplegiaandright- sidedgazepreferencewithdenseleft-
sidedhemineglect. TheNIHSSscorewas17.HeadCTscanrevealed effacementofcortical
sulcalmarkingintherightmiddlecerebralarteryterritoryandhyperdenseMCAsign.
 What is your diagnosis of the
stroke ?
 What are the next you will do ?
POOR PREDICTORS OF
THROMBOLYIS
 Marked hyperglycemia
 CT >1/3 MCA
 Increasing stroke
severity
 Low platelet counts
•Higher NIHSS score
•Longer time to
recanalization
•Lower platelet counts
•Higher glucose level at
admission
SUMMARY
• CT within 20 minutes
• Door-to-needle time within 60 minutes .
• EVT, ECG, troponin should not delay IV t-PA.
• Only the assessment of blood glucose must precede the
initiation of IV t-PA
• Receive IV t-PA: BP <185/110 mmHg
• IV t-PAfor AIS < 3hr
SUMMARY
IV t-PA for AIS < 3 – 4.5
 Class I
 for pts ≤80 y
 without both DM and stroke ,
 NIHSS ≤25,
 not taking any OACs,
 <1/3 MCA territory by CT or MRI
SUMMARY
 Class IIa
 for pts >80 y
 Class IIb
 Taking OACs and INR ≤1.7 and/or PT <15 s
 with both DM and stroke history
SUMMARY
Endovascular Therapy
 Class I
 AIS < 6 hr
 AIS < 6-16 hr: DAWN or DEFUSE 3 criteria
 Class IIa
 AIS < 6-24 hr: DAWN criteria
REFERENSES
 Harrison’s principles of internal medicine 20th edition
 Adam’s and victors principles of neurology 10th edition
 2018 ACC/AHA guidelines for management of acute
ischemic stroke.
THANK YOU

More Related Content

What's hot

Increased Intracranial Pressure
Increased Intracranial PressureIncreased Intracranial Pressure
Increased Intracranial Pressure
Tosca Torres
 
hypokalemic periodic paralysis
hypokalemic periodic paralysishypokalemic periodic paralysis
hypokalemic periodic paralysis
laxmikant joshi
 

What's hot (20)

Septic shock management (1)
Septic shock management (1)Septic shock management (1)
Septic shock management (1)
 
Pediatric Head Trauma
Pediatric Head TraumaPediatric Head Trauma
Pediatric Head Trauma
 
Coma
ComaComa
Coma
 
Syndrome of Inappropriate Anti-diuretic Hormone Secretion (SIADH)
Syndrome of Inappropriate Anti-diuretic Hormone Secretion (SIADH)Syndrome of Inappropriate Anti-diuretic Hormone Secretion (SIADH)
Syndrome of Inappropriate Anti-diuretic Hormone Secretion (SIADH)
 
Increased Intracranial Pressure
Increased Intracranial PressureIncreased Intracranial Pressure
Increased Intracranial Pressure
 
Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]
 
Hypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatmentHypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatment
 
Hyponatremia and hypernatremia
Hyponatremia and hypernatremiaHyponatremia and hypernatremia
Hyponatremia and hypernatremia
 
Status epilepticus
Status epilepticusStatus epilepticus
Status epilepticus
 
Head injury.ppt
Head injury.pptHead injury.ppt
Head injury.ppt
 
Hemorrhagic stroke
Hemorrhagic stroke Hemorrhagic stroke
Hemorrhagic stroke
 
hyponatremia
hyponatremiahyponatremia
hyponatremia
 
DKA
DKADKA
DKA
 
Brain death
Brain deathBrain death
Brain death
 
hypokalemic periodic paralysis
hypokalemic periodic paralysishypokalemic periodic paralysis
hypokalemic periodic paralysis
 
Guillain barre syndrome
Guillain barre syndromeGuillain barre syndrome
Guillain barre syndrome
 
status epilepticus presentation
status epilepticus presentation status epilepticus presentation
status epilepticus presentation
 
Hsv encephalitis final
Hsv encephalitis finalHsv encephalitis final
Hsv encephalitis final
 
Guidelines for management of acute stroke
Guidelines for management of acute strokeGuidelines for management of acute stroke
Guidelines for management of acute stroke
 
Hyperkalemia
HyperkalemiaHyperkalemia
Hyperkalemia
 

Similar to Acute Ischemic Stroke - Etiopathogenesis, Clinical features, Advances in Management

Stroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptxStroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptx
Roop
 
dental management patients with cardiovascular disorders.pptx
dental management patients with cardiovascular disorders.pptxdental management patients with cardiovascular disorders.pptx
dental management patients with cardiovascular disorders.pptx
Pooja461465
 
Stroke emergency treatment
Stroke emergency treatmentStroke emergency treatment
Stroke emergency treatment
PS Deb
 
Stroke emergency treatment for 26th march 00
Stroke emergency treatment for 26th march 00Stroke emergency treatment for 26th march 00
Stroke emergency treatment for 26th march 00
PS Deb
 
MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER
MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER
MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER
Praveen Nagula
 
CARDIO PULMONARY RESUSITATION.pptx
CARDIO PULMONARY RESUSITATION.pptxCARDIO PULMONARY RESUSITATION.pptx
CARDIO PULMONARY RESUSITATION.pptx
GulnarShah1
 

Similar to Acute Ischemic Stroke - Etiopathogenesis, Clinical features, Advances in Management (20)

Stroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptxStroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptx
 
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
 
htn crisis ....pptx
htn crisis ....pptxhtn crisis ....pptx
htn crisis ....pptx
 
dental management patients with cardiovascular disorders.pptx
dental management patients with cardiovascular disorders.pptxdental management patients with cardiovascular disorders.pptx
dental management patients with cardiovascular disorders.pptx
 
Cerebrovascular accident (CVA)
Cerebrovascular accident (CVA) Cerebrovascular accident (CVA)
Cerebrovascular accident (CVA)
 
Hemodynamic Management afer Cardiac Arrest
Hemodynamic Management afer Cardiac ArrestHemodynamic Management afer Cardiac Arrest
Hemodynamic Management afer Cardiac Arrest
 
Stroke emergency treatment
Stroke emergency treatmentStroke emergency treatment
Stroke emergency treatment
 
Stroke management
Stroke managementStroke management
Stroke management
 
Stroke emergency treatment for 26th march 00
Stroke emergency treatment for 26th march 00Stroke emergency treatment for 26th march 00
Stroke emergency treatment for 26th march 00
 
ACS.ppt
ACS.pptACS.ppt
ACS.ppt
 
Acute ischemic stroke
Acute ischemic strokeAcute ischemic stroke
Acute ischemic stroke
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
HYPERTENSIVE CRISIS
HYPERTENSIVE CRISISHYPERTENSIVE CRISIS
HYPERTENSIVE CRISIS
 
Cerebrovascular accident
Cerebrovascular  accidentCerebrovascular  accident
Cerebrovascular accident
 
Supportive treatment in stroke
Supportive treatment in strokeSupportive treatment in stroke
Supportive treatment in stroke
 
Stroke (Cerebrovascular Accident)
Stroke (Cerebrovascular Accident)Stroke (Cerebrovascular Accident)
Stroke (Cerebrovascular Accident)
 
Stroke
StrokeStroke
Stroke
 
MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER
MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER
MANAGEMENT OF ANTERIOR WALL MI WITH SHOCK IN A NON PCI CENTER
 
Stroke/Cerebrovascular accident - Medicine - ATOT
Stroke/Cerebrovascular accident - Medicine - ATOTStroke/Cerebrovascular accident - Medicine - ATOT
Stroke/Cerebrovascular accident - Medicine - ATOT
 
CARDIO PULMONARY RESUSITATION.pptx
CARDIO PULMONARY RESUSITATION.pptxCARDIO PULMONARY RESUSITATION.pptx
CARDIO PULMONARY RESUSITATION.pptx
 

More from Chetan Ganteppanavar

More from Chetan Ganteppanavar (20)

Acid base disorders - acidosis alkalosis metabolic respiratory
Acid base disorders -  acidosis alkalosis metabolic respiratoryAcid base disorders -  acidosis alkalosis metabolic respiratory
Acid base disorders - acidosis alkalosis metabolic respiratory
 
Hepatitis C - Etiology Pathogenesis Clinical Features Diagnosis Management
Hepatitis C - Etiology Pathogenesis Clinical Features Diagnosis ManagementHepatitis C - Etiology Pathogenesis Clinical Features Diagnosis Management
Hepatitis C - Etiology Pathogenesis Clinical Features Diagnosis Management
 
Disorders of Parathyroid Gland
Disorders of Parathyroid GlandDisorders of Parathyroid Gland
Disorders of Parathyroid Gland
 
Multistep Carcinogenesis
Multistep CarcinogenesisMultistep Carcinogenesis
Multistep Carcinogenesis
 
Compressive myelopathy - Etiology, Pathogenesis, Clinical Features, Classific...
Compressive myelopathy - Etiology, Pathogenesis, Clinical Features, Classific...Compressive myelopathy - Etiology, Pathogenesis, Clinical Features, Classific...
Compressive myelopathy - Etiology, Pathogenesis, Clinical Features, Classific...
 
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
 
Peripheral neuropathy Anatomy, Physiology and Diseases
Peripheral neuropathy  Anatomy, Physiology and DiseasesPeripheral neuropathy  Anatomy, Physiology and Diseases
Peripheral neuropathy Anatomy, Physiology and Diseases
 
Autonomic Nervous System (ANS) - Anatomy and Physiology
Autonomic Nervous System (ANS) - Anatomy and PhysiologyAutonomic Nervous System (ANS) - Anatomy and Physiology
Autonomic Nervous System (ANS) - Anatomy and Physiology
 
Extrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemExtrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal System
 
Enteral nutrition - Modes, Indications, Complications
Enteral nutrition - Modes, Indications, ComplicationsEnteral nutrition - Modes, Indications, Complications
Enteral nutrition - Modes, Indications, Complications
 
Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle - PDH and TCA
Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle - PDH and TCAPyruvate Dehydrogenase and Tricarboxylic Acid Cycle - PDH and TCA
Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle - PDH and TCA
 
Amputation
AmputationAmputation
Amputation
 
Jaundice - Etiology, pathogenesis, Clinical features, Investigation, Treatmen...
Jaundice - Etiology, pathogenesis, Clinical features, Investigation, Treatmen...Jaundice - Etiology, pathogenesis, Clinical features, Investigation, Treatmen...
Jaundice - Etiology, pathogenesis, Clinical features, Investigation, Treatmen...
 
Immunoglobulins
ImmunoglobulinsImmunoglobulins
Immunoglobulins
 
Hexose Monophosphate Shunt Pathway - HMP Pathway
Hexose Monophosphate Shunt Pathway - HMP PathwayHexose Monophosphate Shunt Pathway - HMP Pathway
Hexose Monophosphate Shunt Pathway - HMP Pathway
 
Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
Hemoglobinopathies
 
Heme synthesis and porphyrias
Heme synthesis and porphyriasHeme synthesis and porphyrias
Heme synthesis and porphyrias
 
Diabetes mellitus and Insulins
Diabetes mellitus and InsulinsDiabetes mellitus and Insulins
Diabetes mellitus and Insulins
 
Acid Base Balance - Biochemistry of human homeostasis
Acid Base Balance - Biochemistry of human homeostasisAcid Base Balance - Biochemistry of human homeostasis
Acid Base Balance - Biochemistry of human homeostasis
 
Bacterial meningitis - Etiology, pathogenesis, Clinical features, Investigati...
Bacterial meningitis - Etiology, pathogenesis, Clinical features, Investigati...Bacterial meningitis - Etiology, pathogenesis, Clinical features, Investigati...
Bacterial meningitis - Etiology, pathogenesis, Clinical features, Investigati...
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 

Acute Ischemic Stroke - Etiopathogenesis, Clinical features, Advances in Management

  • 1. CHAIR PERSON – DR. KALINGA.B.E STUDENT – DR. MAMATARANI MANAGEMENT OF ACUTE ISCHEMIC STROKE
  • 2. WHO DEFINITION OF STROKE A NEUROLOGICAL DEFICIT OF • Sudden onset • With focal rather than global dysfunction • In which, after adequate investigations, symptoms are presumed to be of non-traumatic vascular origin and • last for >24 hours
  • 4.
  • 5.
  • 7.
  • 8. Principles of acute stroke care (1) achieve timely recanalization of the occluded artery and reperfusion of the ischemic tissue, (2) optimize collateral flow, and (3) avoid secondary brain injury.
  • 9.
  • 10. Stroke Risk Factors Non- modifiable  AGE  Gender - male  Race – Blacks > Asians or Hispanics> Whites  Family History.  Coagulation Disorders  Cardiac Disease
  • 11. Stroke Risk Factors Modifiable  Hypertension  Diabetes mellitus  Hypercholesterolemia  Elevated LDL or Low HDL  Elevated homocystein  Smoking • Alcohol Abuse •OralContraceptive • Pregnancy •Obesity •Sleep apnea •Carotid stenosis
  • 12. Stroke chain of survival  Detection Recognition of stroke signs/symptoms  Dispatch Call 119 and priority EMS dispatch  Delivery Prompt transport and prehospital notification to Hospital  Door Immediate ED triage  Data ED evaluation, prompt laboratory studies, and CT Imaging  Decision Diagnosis and decision about appropriate therapy  Drug Administration of appropriate drugs or other intervention
  • 13. EMERGENCY EVALUATION OF ACUTE ISCHEMIC STROKE  Assess ABCs, vital signs  Provide oxygen by nasal cannula wherever necessary  Obtain IV access; obtain blood samples (CBC, ’lytes, coagulation studies)  Obtain 12-lead ECG, check rhythm, place on monitor  Check blood sugar; treat if indicated
  • 14.
  • 15. NIHSS
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. MEDICAL MANAGEMENT  Supportive treatment  IV thrombolysis  Endovascular revascularization  Anti thrombotic tretment  Neuroprotection  Stroke centers and Rehabilitation
  • 21. SURGICAL MANAGEMENT  Endovascular intervention 1.angioplasty and stenting 2. Mechanical clot disruption 3. clot extraction • Carotid end artrectomy
  • 22. MANAGEMENT OF COMPLICATION  Cerebral edema  Hemorrhagic transformation  seizures
  • 23. SUPPORTIVE TREATMENT  Airway, Breathing and Circulation.  Temperature  Blood pressure  Blood glucose
  • 24. When to lower Blood pressure  the hypertension is extreme (systolic blood pressure >220 mmHg or diastolic blood pressure >120 mmHg)  Acute myocardial infarction  Aortic dissection  Hypertensive encephalopathy  Acute renal failure
  • 26.
  • 27.  IV rtPA Dose - 0.9mg/kg to a 90mg maximun dose..  Before IV rtPA ensure that blood pressure is not More than 185/110 mmhg  Door to needle time should be within 60min.
  • 28.
  • 29.
  • 31. MECHANICAL / ENDOVASCULAR METHODS  CRITERIA FOR MECHANICAL THROMBECTOMY 1.prestroke mRS score of 0-1 2.occlusion of the internal carotid artery or MCA segment 1 3.age >18yr 4.NIHSS score> 6 5.ASPECT score of >6 6. treatment can be initiated (groin puncture) within 6 hours of sypmtom onset
  • 32.
  • 33.
  • 34.
  • 35. ANTIPLATELETS.  The oral administration of aspirin in AIS is recommended within 24 -48 hrs of symptoms onset.  For those treated with IV alteplase, aspirin administration is generally delayed until 24 hours later
  • 39. CLINICAL SCENARIO  A 70-year-old, right-handed man has been known to have previous historyofpoorlycontrolledhypertension, diabetes,andcardiacarrhythmia. Hedevelopedabrupt onsetofleft-sidedweaknessafterdinnerat7 pm What should you do?
  • 40. • Hebrought to a medicalcenterERbytheEMSat 8:30 pm • OninitialERarrival,hisconsciousnesswasawake, • blood pressure was 210/120 mmHg, pulse rate was 120/min irregularly, respiratory rate was 20/min, body temperaturewas37°Candbloodsugarwas320mg/dL
  • 41.  Neurologically,hehadflaccidhemiplegiaandright- sidedgazepreferencewithdenseleft- sidedhemineglect. TheNIHSSscorewas17.HeadCTscanrevealed effacementofcortical sulcalmarkingintherightmiddlecerebralarteryterritoryandhyperdenseMCAsign.  What is your diagnosis of the stroke ?  What are the next you will do ?
  • 42. POOR PREDICTORS OF THROMBOLYIS  Marked hyperglycemia  CT >1/3 MCA  Increasing stroke severity  Low platelet counts •Higher NIHSS score •Longer time to recanalization •Lower platelet counts •Higher glucose level at admission
  • 43. SUMMARY • CT within 20 minutes • Door-to-needle time within 60 minutes . • EVT, ECG, troponin should not delay IV t-PA. • Only the assessment of blood glucose must precede the initiation of IV t-PA • Receive IV t-PA: BP <185/110 mmHg • IV t-PAfor AIS < 3hr
  • 44. SUMMARY IV t-PA for AIS < 3 – 4.5  Class I  for pts ≤80 y  without both DM and stroke ,  NIHSS ≤25,  not taking any OACs,  <1/3 MCA territory by CT or MRI
  • 45. SUMMARY  Class IIa  for pts >80 y  Class IIb  Taking OACs and INR ≤1.7 and/or PT <15 s  with both DM and stroke history
  • 46. SUMMARY Endovascular Therapy  Class I  AIS < 6 hr  AIS < 6-16 hr: DAWN or DEFUSE 3 criteria  Class IIa  AIS < 6-24 hr: DAWN criteria
  • 47. REFERENSES  Harrison’s principles of internal medicine 20th edition  Adam’s and victors principles of neurology 10th edition  2018 ACC/AHA guidelines for management of acute ischemic stroke.